Concord Medical Services (NYSE:CCM) Stock Crosses Above 200-Day Moving Average – Should You Sell?

Concord Medical Services Holdings Limited (NYSE:CCM) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $4.14 and traded as high as $5.11. Concord Medical Services shares last traded at $4.7450, with a volume of 5,612 shares.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Concord Medical Services Stock Down 1.7%

The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The company’s 50-day moving average is $4.43 and its two-hundred day moving average is $4.15.

Concord Medical Services (NYSE:CCM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.